75 related articles for article (PubMed ID: 12425820)
1. [Induction of human cervical carcinoma by human papilloma virus and tumor promoters].
Cao Z; Zhao J; Guo X; Liao Q; Zhang Y; Zhang Y; Zeng Y
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1108-10. PubMed ID: 12425820
[TBL] [Abstract][Full Text] [Related]
2. [Induction of human oral carcinoma by human papillomavirus 16 E6/E7 and TPA].
Zhao J; Cao ZY; Sun YT; Liao QP; Du HJ; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):234-6. PubMed ID: 15340565
[TBL] [Abstract][Full Text] [Related]
3. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
4. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
5. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
[TBL] [Abstract][Full Text] [Related]
6. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
7. [Growth behavior and metastatic pattern of cervical cancer U14 transfected with human papillomavirus in inbred mouse].
Tao GS; Yang SB; Lin QH
Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):515-9. PubMed ID: 12536526
[TBL] [Abstract][Full Text] [Related]
8. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
9. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
Lathion S; Schaper J; Beard P; Raj K
Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
11. [Immortalization of human embryonic cervical epithelial cells induced by E6, E7 genes of human papillomavirus 16].
Cao ZY; Zhao J; Liao QP; Yang YS; Zhou L; Zeng Y
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):486-8. PubMed ID: 15347475
[TBL] [Abstract][Full Text] [Related]
12. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
Cheung YK; Cheng SC; Sin FW; Xie Y
Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
[TBL] [Abstract][Full Text] [Related]
13. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
14. [The inhibitory effect of antisense--RNA of papillomavirus type 16 E6E7 genes on malignant phenotypes of cervical carcinoma cell line].
Ming L; Zhou L; Shang M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):54-7. PubMed ID: 12515173
[TBL] [Abstract][Full Text] [Related]
15. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme targeted on HPV16E6 mRNA induced apoptosis on human cervical carcinoma CaSKi cells.
Zheng YF; Zhang JR
Ai Zheng; 2003 May; 22(5):458-62. PubMed ID: 12753702
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
18. [Detection of HPV 58 and cloning of its E7 gene in cervical cancer].
Gao YE; Zhang J; Chen ZC; Song TB; Zhao Y; Zhang GL; Yan XJ
Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):543-6. PubMed ID: 15555285
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-HPV16E6-ribozyme on phenotype and gene expression of a cervical cancer cell line.
Zheng Y; Zhang J; Qu L
Chin Med J (Engl); 2002 Oct; 115(10):1501-6. PubMed ID: 12490096
[TBL] [Abstract][Full Text] [Related]
20. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]